Armata Pharmaceuticals (ARMP) Profit After Tax (2013 - 2026)
Armata Pharmaceuticals (ARMP) reported Profit After Tax of -$115.3 million for Q1 2026, down 1666.13% on a YoY basis from $7.4 million in Q1 2025, and up 7.2% sequentially from -$124.3 million in Q4 2025.
Armata Pharmaceuticals (ARMP) Profit After Tax (2013 - 2026) Analysis & Trends
Armata Pharmaceuticals (ARMP) has 14 years of Profit After Tax data on file, last reported at -$115.3 million in Q1 2026.
- For the quarter ending Q1 2026, Profit After Tax fell 1666.13% year-over-year to -$115.3 million; the trailing twelve-month figure through Mar 2026 stood at -$282.6 million (down 1086.31% YoY), and the FY2025 full-year result was -$173.8 million, down 818.79% from the prior year.
- Profit After Tax grew to -$115.3 million in Q1 2026, from -$124.3 million in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of $2.6 million in Q4 2024 to a low of -$124.3 million in Q4 2025.
- A 5-year average of -$25.7 million and a median of -$14.4 million in 2024 frame the typical range for Profit After Tax.
- Across the five-year window, Profit After Tax jumped 113.1% in 2024 and plunged 4880.69% in 2025, its largest moves.
- Tracing ARMP's Profit After Tax over 5 years: stood at -$10.3 million in 2022, then plunged by 92.43% to -$19.8 million in 2023, then jumped by 113.1% to $2.6 million in 2024, then sank by 4880.69% to -$124.3 million in 2025, then climbed by 7.2% to -$115.3 million in 2026.
- Business Quant data shows ARMP's Profit After Tax at -$115.3 million in Q1 2026, -$124.3 million in Q4 2025, and -$26.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -36.84 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 227.36 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -65.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 362.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | Armata Pharmaceuticals | 191.29 Mn | 186.49 Mn | - | -115.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -115.35 Mn |
| Dec 31, 2025 | -124.30 Mn |
| Sep 30, 2025 | -26.68 Mn |
| Jun 30, 2025 | -16.30 Mn |
| Mar 31, 2025 | -6.53 Mn |
| Dec 31, 2024 | 2.60 Mn |
| Sep 30, 2024 | -5.48 Mn |
| Jun 30, 2024 | -14.41 Mn |
| Mar 31, 2024 | -25.02 Mn |
| Dec 31, 2023 | -19.85 Mn |
| Sep 30, 2023 | -31.16 Mn |
| Jun 30, 2023 | -3.55 Mn |
| Mar 31, 2023 | -14.49 Mn |
| Dec 31, 2022 | -10.31 Mn |
| Sep 30, 2022 | -8.61 Mn |
| Jun 30, 2022 | -9.22 Mn |
| Mar 31, 2022 | -8.77 Mn |
| Dec 31, 2021 | -6.05 Mn |
| Sep 30, 2021 | -5.42 Mn |
| Jun 30, 2021 | -6.19 Mn |